Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0030532 | small nuclear ribonucleoprotein complex | 3 | 12 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0046540 | U4/U6 x U5 tri-snRNP complex | 6 | 12 |
GO:0097525 | spliceosomal snRNP complex | 4 | 12 |
GO:0097526 | spliceosomal tri-snRNP complex | 5 | 12 |
GO:0120114 | Sm-like protein family complex | 2 | 12 |
GO:0140513 | nuclear protein-containing complex | 2 | 12 |
GO:1990904 | ribonucleoprotein complex | 2 | 12 |
GO:0005681 | spliceosomal complex | 3 | 1 |
GO:0005687 | U4 snRNP | 5 | 1 |
GO:0071011 | precatalytic spliceosome | 4 | 1 |
Related structures:
AlphaFold database: A4H8U1
Term | Name | Level | Count |
---|---|---|---|
GO:0000244 | spliceosomal tri-snRNP complex assembly | 8 | 12 |
GO:0000387 | spliceosomal snRNP assembly | 7 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016043 | cellular component organization | 3 | 12 |
GO:0022607 | cellular component assembly | 4 | 12 |
GO:0022618 | ribonucleoprotein complex assembly | 6 | 12 |
GO:0043933 | protein-containing complex organization | 4 | 12 |
GO:0065003 | protein-containing complex assembly | 5 | 12 |
GO:0071826 | ribonucleoprotein complex subunit organization | 5 | 12 |
GO:0071840 | cellular component organization or biogenesis | 2 | 12 |
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 1 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 1 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006396 | RNA processing | 6 | 1 |
GO:0006397 | mRNA processing | 7 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0008380 | RNA splicing | 7 | 1 |
GO:0016070 | RNA metabolic process | 5 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0090304 | nucleic acid metabolic process | 4 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 163 | 165 | PF00675 | 0.439 |
CLV_NRD_NRD_1 | 219 | 221 | PF00675 | 0.488 |
CLV_NRD_NRD_1 | 93 | 95 | PF00675 | 0.228 |
CLV_PCSK_FUR_1 | 164 | 168 | PF00082 | 0.585 |
CLV_PCSK_KEX2_1 | 157 | 159 | PF00082 | 0.460 |
CLV_PCSK_KEX2_1 | 166 | 168 | PF00082 | 0.429 |
CLV_PCSK_KEX2_1 | 221 | 223 | PF00082 | 0.515 |
CLV_PCSK_PC1ET2_1 | 157 | 159 | PF00082 | 0.434 |
CLV_PCSK_PC1ET2_1 | 166 | 168 | PF00082 | 0.464 |
CLV_PCSK_PC1ET2_1 | 221 | 223 | PF00082 | 0.515 |
CLV_PCSK_SKI1_1 | 122 | 126 | PF00082 | 0.435 |
CLV_PCSK_SKI1_1 | 195 | 199 | PF00082 | 0.368 |
CLV_PCSK_SKI1_1 | 224 | 228 | PF00082 | 0.585 |
CLV_PCSK_SKI1_1 | 95 | 99 | PF00082 | 0.293 |
DEG_SCF_FBXO31_1 | 233 | 239 | PF12014 | 0.646 |
DOC_ANK_TNKS_1 | 126 | 133 | PF00023 | 0.560 |
DOC_CKS1_1 | 1 | 6 | PF01111 | 0.345 |
DOC_CYCLIN_RxL_1 | 192 | 202 | PF00134 | 0.444 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 1 | 10 | PF00134 | 0.416 |
DOC_CYCLIN_yCln2_LP_2 | 142 | 148 | PF00134 | 0.588 |
DOC_MAPK_gen_1 | 118 | 125 | PF00069 | 0.393 |
DOC_MAPK_MEF2A_6 | 118 | 125 | PF00069 | 0.380 |
DOC_PP1_RVXF_1 | 120 | 126 | PF00149 | 0.443 |
DOC_PP2B_LxvP_1 | 142 | 145 | PF13499 | 0.434 |
DOC_PP2B_LxvP_1 | 62 | 65 | PF13499 | 0.532 |
DOC_USP7_MATH_1 | 48 | 52 | PF00917 | 0.507 |
DOC_USP7_UBL2_3 | 118 | 122 | PF12436 | 0.467 |
DOC_USP7_UBL2_3 | 162 | 166 | PF12436 | 0.488 |
DOC_USP7_UBL2_3 | 217 | 221 | PF12436 | 0.543 |
DOC_USP7_UBL2_3 | 83 | 87 | PF12436 | 0.538 |
LIG_14-3-3_CanoR_1 | 179 | 186 | PF00244 | 0.461 |
LIG_AP2alpha_1 | 67 | 71 | PF02296 | 0.443 |
LIG_APCC_ABBAyCdc20_2 | 63 | 69 | PF00400 | 0.520 |
LIG_BIR_III_4 | 69 | 73 | PF00653 | 0.443 |
LIG_BRCT_BRCA1_1 | 142 | 146 | PF00533 | 0.472 |
LIG_FHA_1 | 1 | 7 | PF00498 | 0.441 |
LIG_FHA_1 | 137 | 143 | PF00498 | 0.391 |
LIG_FHA_1 | 179 | 185 | PF00498 | 0.563 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.544 |
LIG_FHA_2 | 133 | 139 | PF00498 | 0.611 |
LIG_FHA_2 | 225 | 231 | PF00498 | 0.439 |
LIG_Integrin_RGD_1 | 150 | 152 | PF01839 | 0.591 |
LIG_LIR_Gen_1 | 143 | 154 | PF02991 | 0.491 |
LIG_LIR_Gen_1 | 229 | 239 | PF02991 | 0.521 |
LIG_LIR_Gen_1 | 41 | 48 | PF02991 | 0.538 |
LIG_LIR_Nem_3 | 143 | 149 | PF02991 | 0.481 |
LIG_LIR_Nem_3 | 229 | 234 | PF02991 | 0.515 |
LIG_LIR_Nem_3 | 41 | 47 | PF02991 | 0.538 |
LIG_NRBOX | 5 | 11 | PF00104 | 0.538 |
LIG_PDZ_Class_2 | 234 | 239 | PF00595 | 0.519 |
LIG_Pex14_2 | 67 | 71 | PF04695 | 0.446 |
LIG_RPA_C_Fungi | 122 | 134 | PF08784 | 0.350 |
LIG_SH2_STAT5 | 148 | 151 | PF00017 | 0.549 |
LIG_SUMO_SIM_anti_2 | 172 | 178 | PF11976 | 0.491 |
LIG_TRAF2_1 | 169 | 172 | PF00917 | 0.594 |
LIG_TRAF2_1 | 189 | 192 | PF00917 | 0.455 |
LIG_UBA3_1 | 25 | 30 | PF00899 | 0.345 |
MOD_CK1_1 | 109 | 115 | PF00069 | 0.339 |
MOD_CK1_1 | 46 | 52 | PF00069 | 0.487 |
MOD_CK2_1 | 109 | 115 | PF00069 | 0.374 |
MOD_CK2_1 | 186 | 192 | PF00069 | 0.540 |
MOD_CK2_1 | 224 | 230 | PF00069 | 0.444 |
MOD_Cter_Amidation | 92 | 95 | PF01082 | 0.416 |
MOD_GlcNHglycan | 20 | 23 | PF01048 | 0.263 |
MOD_GSK3_1 | 132 | 139 | PF00069 | 0.587 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.422 |
MOD_NEK2_1 | 18 | 23 | PF00069 | 0.364 |
MOD_NEK2_1 | 216 | 221 | PF00069 | 0.630 |
MOD_PIKK_1 | 136 | 142 | PF00454 | 0.460 |
MOD_PIKK_1 | 178 | 184 | PF00454 | 0.518 |
MOD_PKA_2 | 178 | 184 | PF00069 | 0.518 |
MOD_PKB_1 | 222 | 230 | PF00069 | 0.444 |
MOD_Plk_4 | 172 | 178 | PF00069 | 0.565 |
MOD_SUMO_rev_2 | 75 | 85 | PF00179 | 0.345 |
TRG_DiLeu_BaLyEn_6 | 124 | 129 | PF01217 | 0.438 |
TRG_ENDOCYTIC_2 | 231 | 234 | PF00928 | 0.503 |
TRG_ER_diArg_1 | 183 | 186 | PF00400 | 0.503 |
TRG_NLS_MonoExtC_3 | 219 | 224 | PF00514 | 0.499 |
TRG_NLS_MonoExtN_4 | 217 | 224 | PF00514 | 0.521 |
TRG_Pf-PMV_PEXEL_1 | 127 | 131 | PF00026 | 0.475 |
TRG_Pf-PMV_PEXEL_1 | 195 | 199 | PF00026 | 0.442 |
TRG_Pf-PMV_PEXEL_1 | 37 | 42 | PF00026 | 0.366 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBE4 | Leptomonas seymouri | 73% | 100% |
A0A0S4JJR8 | Bodo saltans | 29% | 85% |
A0A1X0P0A6 | Trypanosomatidae | 51% | 100% |
A0A3S7WU78 | Leishmania donovani | 93% | 100% |
A0A422NE48 | Trypanosoma rangeli | 51% | 100% |
A4HX61 | Leishmania infantum | 92% | 100% |
C9ZVT0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 81% |
E9AQX6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q4QEK2 | Leishmania major | 91% | 100% |
V5BSA7 | Trypanosoma cruzi | 50% | 100% |